{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:18:39Z","timestamp":1780420719911,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2022.865334","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T06:25:12Z","timestamp":1647584712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Interstitial Lung Disease Around the World"],"prefix":"10.3389","volume":"9","author":[{"given":"Marlies","family":"Wijsenbeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarir","family":"Udwadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/lungindia.lungindia_414_20","article-title":"Survival predictors of interstitial lung disease in India: follow-up of Interstitial Lung Disease India registry","volume":"38","author":"Singh","year":"2021","journal-title":"Lung India"},{"key":"B6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4103\/lungindia.lungindia_263_19","article-title":"Hypersensitivity pneumonitis: clinical manifestations - prospective data from the interstitial lung disease-India registry","volume":"36","author":"Singh","year":"2019","journal-title":"Lung India"},{"key":"B7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","article-title":"Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey","volume":"38","author":"Olson","year":"2020","journal-title":"Adv Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"180077","DOI":"10.1183\/16000617.0077-2018","article-title":"The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype","volume":"27","author":"Olson","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.socscimed.2019.05.033","article-title":"China's dusty lung crisis: rural-urban health inequity as social and spatial injustice","volume":"233","author":"Liu","year":"2019","journal-title":"Soc Sci Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1183\/13993003.01204-2015","article-title":"European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers","volume":"47","author":"Bonella","year":"2016","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","article-title":"The Lancet Commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2102969","DOI":"10.1183\/13993003.02969-2021.","article-title":"Gender and racial equity in clinical research for idiopathic pulmonary fibrosis: a systematic review and meta-analysis","author":"Jalbert","year":"2022","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1164\/rccm.201610-2019ED","article-title":"Interstitial lung disease in india. keep searching and you'll keep finding","volume":"195","author":"Udwadia","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000422","DOI":"10.1136\/bmjresp-2019-000422","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2102527","DOI":"10.1183\/13993003.02527-2021","article-title":"Success and continuous growth of the ERS clinical research collaborations","volume":"58","author":"van den Berge","year":"2021","journal-title":"Eur Respir J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"00405","DOI":"10.1183\/23120541.00405-2021","article-title":"Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era","volume":"7","author":"Nakshbandi","year":"2021","journal-title":"ERJ Open Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12889-020-08876-2","article-title":"Predictors of silicosis and variation in prevalence across mines among employed gold miners in South Africa","volume":"20","author":"Knight","year":"2020","journal-title":"BMC Public Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217652.","article-title":"Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosis","author":"Avitzur","year":"2021","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/thoraxjnl-2017-210952","article-title":"Impact of improved cookstoves on women's and child health in low and middle income countries: a systematic review and meta-analysis","volume":"73","author":"Thakur","year":"2018","journal-title":"Thorax"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries- a systematic review","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.865334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T06:25:14Z","timestamp":1647584714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.865334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":23,"alternative-id":["10.3389\/fmed.2022.865334"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.865334","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"article-number":"865334"}}